Some stocks might be struggling in 2020, but not Quest Diagnostics (NYSE:DGX). The diagnostics information services provider's shares were up more than 20% as of the market close on Wednesday.
Quest announced its second-quarter results before the market opened on Thursday. Were those results good enough for the company to keep its momentum going? Here are the highlights from Quest's Q2 update.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,